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Abstract
Objectives—Cervical cancer is the leading cause of cancer deaths among women in Haiti. Given 
this high disease burden, we sought to better understand women’s knowledge of its causes and the 
socio-demographic and health correlates of cervical cancer screening.
Methods—Participants were 410 adult women presenting at clinics in Léogâne and Port-au-
Prince, Haiti. We used bivariate and multivariate logic regression to identify correlates of Pap 
smear receipt.
Results—Only 29% of respondents had heard of human papillomavirus (HPV), while 98% were 
aware of cervical cancer. Of those aware of cervical cancer, 12% believed sexually transmitted 
infections (STIs) cause it, and only 4% identified HPV infection as the cause. Women with a 
previous STI were more likely to have had Pap smear (34% vs. 71%, OR=3.45; 95% CI: 1.57–
7.59). Screening was also more likely among women who were older than age 39, better educated 
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and employed (all p<.05). Almost all women (97%) were willing to undergo cervical cancer 
screening.
Conclusions—This sample of Haitian women had limited awareness of HPV and cervical 
cancer causes; but when provided with health information, they saw the benefits of cancer 
screening. Future initiatives should provide health education messages, with efforts targeting 
young and at-risk women.
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INTRODUCTION
Worldwide, invasive cervical cancer is the most common cancer in women ages 15–44 years 
and is caused by chronic infection with human papillomavirus (HPV) [1]. Developing 
nations makeup 87% of the global burden of cervical cancer [2]. Countries in Latin America 
and the Caribbean have age-adjusted incidence rates of cervical cancer ranging from 11 to 
47 per 100,000 women per year which are considered high [3–5]. The most recent estimate 
of cervical cancer incidence in Haiti is 20.3 per 100,000 women, which is about 2 ½ times 
higher than the US [1, 6, 7]. The prevalence of oncogenic strains of HPV in Haiti may be as 
high as 19% among semi-urban and urban populations [8, 9].
Invasive cervical cancer can be prevented via early detection, diagnosis and treatment of 
dysplastic cervical lesions [10]. Currently, cytology screening using Papanicolau (Pap) 
smears is the standard for cervical cancer prevention in both the US and Haiti [9–13], but 
HPV DNA testing as primary screening may increase accuracy while reducing requirements 
for trained clinicians to screen in low-resource settings [14–20].
As there is little published data on cervical cancer screening in Haiti, we wanted to better 
understand how Haitian women think about cervical cancer to identify possible 
opportunities and challenges facing future programs. First, we sought to ascertain the 
opinions of Haitian women regarding the causes of cervical cancer and socio-demographic 
and health correlates of a cervical cancer screening. Additionally, we sought to understand 
factors that may influence a woman’s likelihood to screen for cervical cancer in the future.
METHODS
Institutional Review Board Approvals
Institutional review boards at Duke University (Durham, North Carolina, US: protocol 
number CO162) and Misyon Sante Fanme Ayisyen (Port-au-Prince, Haiti; protocol number 
17_03_2014) approved our study on February 22, 2014 and March 14, 2014 respectively. 
Participants provided consent orally through a Haitian Creole translator. This method of 
consent was necessary due to the high rate of illiteracy among the Haitian population. 
Afterwards, participants signed their name or mark to confirm consent to participate or 
consented for a designee to sign on their behalf, and forms were maintained by study 
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researchers. Participants received no monetary reward or incentives to participate in the 
study.
Participants and Procedures
Between April and July 2014, we conducted a cross-sectional survey of patients presenting 
at two health clinics in Haiti. One clinic that primarily focused on cervical cancer screening 
was located in Terre Noire district, a low-income neighborhood of Port-au-Prince. The 
second clinic that provided patients with general health care services was located in 
Léogâne, a port community about 20 miles west of Port-au-Prince of approximately 90,000 
residents. All patients were screened and consented for participation as part of regular clinic 
visits.
All participants were surveyed privately by teams of US university students and local 
Haitian translators in separate clinic rooms after consenting to participate. All surveys were 
conducted orally, with all questions read to the participant in Creole and translated into 
English by the local Haitian translator for recording. The survey took an average of 30 
minutes to complete.
The survey tool was a modification of one previously used to explore awareness and use of 
cervical cancer screening in Botswana [21]. An independent contractor, CreoleTrans, 
translated the modified survey into Haitian Creole. Local clinical research staff reviewed and 
corrected the translated survey tool for clarity.
Measures
The primary outcome was previous screening for cervical cancer, assessed by a question that 
asked women whether they have ever had a Pap smear. The response options were “yes” or 
“no.” Women who were aware of cervical cancer were asked to list up to 3 beliefs of causes 
of cervical cancer and 3 beliefs about health consequences or results of having cervical 
cancer. The survey also asked participants about their willingness to be screened for cervical 
cancer in the future and their reasons for such decisions. The survey assessed the following 
socio-demographic and health characteristics: age, marital status, education, employment 
status, religious background, parental status, history of STIs, contraceptive use, and 
awareness of HPV, genital warts, and someone with cervical cancer. Open-ended questions 
were coded using an iterative process. Two authors (MG, WC) read through responses, 
created categories based on main themes, and met to resolve discrepancies.
Data Analysis
We used bivariate and multivariate regression models to examine correlates of ever having 
received cervical cancer screening. Analyses were conducted using Stata version 14 (College 
Station, TX). Statistical tests were two-tailed and used a standard of p<0.05 for statistical 
significance.
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RESULTS
Four hundred and ten female respondents completed the interview. The majority of 
respondents were younger than age 40, employed, married or living with a partner, had at 
least one child, and had completed primary education (Table 1). Women visiting the clinic in 
Léogâne were younger and less likely to be currently employed, to have had children, to 
have had a STI, or to use contraception than women at the Terre Noire clinic (p<0.05 for 
all). Women in the Léogâne clinic were also less likely to be aware of HPV or genital warts 
(both p<0.05).
Overall, only 29% of women stated they had heard of HPV, while almost all women (98%) 
were aware of cervical cancer (Table 1). Of women who had heard of cervical cancer, 51% 
said the cause was either vaginal infection or gynecological problems (Table 2). Other causal 
beliefs included sexual behavior (41%) such as unprotected sex or multiple sex partners, 
poor general hygiene (21%), and abortion (17%). Only 12% said that STIs may cause 
cervical cancer, and just 4% identified HPV infection as the cause of cervical cancer. When 
asked what they believed would happen to a woman with cervical cancer, most respondents 
stated that she would have vaginal issues (51%) and frequent periods or bleeding (44%) 
(Table 3). As many as 36% of respondents believed death is imminent once a woman has 
cervical cancer. Few women identified an infection or STI as an outcome of cervical lesions 
or cancer.
Of the 410 women respondents, 153 (37%) had previously undergone cervical cancer 
screening (Table 4). In multivariable analysis, women older than 40 years were more likely 
to have had a Pap smear than younger women (OR = 3.09; 95 CI: 1.77–5.41). Additionally, 
women with a history of STI diagnosis were three times more likely to have had a Pap smear 
(OR= 3.45; 95% CI: 1.57–7.59). In bivariate models but not multivariable analysis, other 
noteworthy factors which correlate with a woman’s likelihood to have ever been screened 
include employment status (OR = 4.77; 95 CI: 2.68–8.50), whether a woman ever had 
children (OR = 3.97; 95 CI: 2.33–6.76) and awareness of HPV (OR=2.39; 95 CI: 1.54–
3.70).
Overall, this sample of Haitian women had limited awareness of HPV and cervical cancer 
causes; but when provided with health information, they saw the benefits of cancer 
screening. Almost all women (97%) were willing to undergo cervical cancer screening if 
given the opportunity. Among those women desiring cervical cancer screening (Table 5), the 
primary reason noted was prevention (89%). Other reasons noted include medical 
recommendation (14%), early treatment (9%), and to check for cancer (8%).
DISCUSSION
Main finding of this study
Our study highlights the need for increased public awareness in order to effectively reduce 
the burden of cervical disease among women in Haiti. Even Haitian women previously 
screened for cervical cancer may have limited awareness of cervical cancer causes. 
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Additionally, age and having a history of STI diagnosis were strong correlates of having had 
a cervical cancer screening.
Regardless of low awareness of HPV, almost all women were aware of cervical cancer as a 
disease, and one-third personally knew someone who had had cervical cancer. Women in 
this study clearly understood the benefits of screening to prevent cervical cancer progression 
after receiving basic health information and were very willing to be screened if given an 
opportunity to do so. As cervical cancer has become an increasing priority for the Ministry 
of Health due to the high disease burden [(Cornerly, Jean Ronald, MD. “Letter of Invitation 
to Collaborate in National Cervical Cancer Screening Program.” Letter to Dr. David Walmer. 
20 April 2015. MS. Ministère de la Santé Publique et de la Population, Port-au-Prince, 
Haiti.), (Thimothe, Gabriel, MD. “Human Papilloma Virus Screening Support Letter.” Letter 
to Family Health Ministries. 02 Sept. 2011. MS. Ministère de la Santé Publique et de la 
Population, Port-au-Prince, Haiti.)], efforts to rapidly increase screening across Haiti would 
likely be favored by the majority of women with a small adjunctive education effort.
What is already known
Health care infrastructure in Haiti has historically reached only about 60% of the population 
[22]; so, additional efforts around infrastructure strengthening are critical. Accessibility 
challenges were exacerbated with the massive destruction caused by the 2010 earthquake 
[23]. Several aid programs are making important strides in the re-establishment and the 
building of healthcare infrastructure throughout Haiti [23]. All the same, in the absence of 
effective cervical cancer treatment facilities [9, 22], little advancement can be gained from 
diagnosis without treatment. As such, the Haitian Ministry of Health is aggressively working 
with collaborative partners to fill this large healthcare gap [(Cornerly 2015), (Thimothe 
2011), 10, 22]. Additional research is needed to determine how best to integrate sustainable 
cervical screening services within existing healthcare settings [9].
Within the Latin America and Caribbean region where cervical cancer screening rates tend 
to be low [4], predictors of screening uptake include marriage, age, parity, provider 
recommendation and knowing someone with cervical cancer [24, 25]. These factors can 
even outweigh cost, as cervical cancer incidence and mortality rates in Jamaica are relatively 
high despite the availability of free screening services throughout the country [24, 26]. In 
this Haitian population, women who were more likely to have a higher income (those with 
higher educational levels and current employment) and those likely to have had 
genitourinary symptoms in the past (those having been diagnosed with STIs) were more 
likely to have been screened for cervical cancer in the past. These correlates should prove 
beneficial to policy makers and program planners, as they identify a large population in 
which to increase awareness efforts.
What this study adds
Our findings provide substantial insight into Haitian women’s low understanding related to 
cervical cancer prevention. Within this population of women, many of whom were 
presenting for cervical cancer screening, only 4% were aware of HPV as the cause of 
cervical cancer. Low awareness of HPV is not unique to this population, as Haitian 
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immigrants in Miami also report limited knowledge of HPV (as low as 22%) [27, 28]. 
Cervical cancer prevention efforts in Haiti should focus on raising awareness about HPV 
infection and its role in cervical cancer.
One potential strategy for future cervical cancer screening efforts would be to spread public 
education messages throughout the general population via radio broadcast to increase overall 
awareness of the need and availability of screening. Alternatively, more targeted efforts 
could be directed toward younger, asymptomatic women less likely to be screened via 
school and clinic-based awareness efforts. For primary healthcare workers, educational 
messages about the etiology of cervical cancer and screening practices should be embedded 
into health training curricula. Likewise, healthcare workers should be encouraged to share 
these messages as standard of care procedures. Additionally, research efforts should work to 
identify women who are most at-risk for developing cervical cancer to further direct 
outreach efforts.
Limitations
Limitations of this research study include the small sample size and need for replication 
before extrapolating our results to the wider population. Likewise, because we recruited both 
cohorts of women in medical settings, participants may be more likely to have access to and 
seek health care. It is also noteworthy that the reasons for presenting at the clinic vary 
between the Port-au-Prince and Leogane cohorts of women. Those presenting in Port-au-
Prince are seeking cervical cancer screening while those in Leogane require general health 
services. As the cervical screening clinic in Port-au-Prince has been in operation since 2009 
while that in Leogane is general practice, the demographic differences between these cohorts 
of women are likely impacted by their need for reproductive health services.
CONCLUSION
We report novel findings on understanding of cervical cancer prevention among a 
convenience sample of Haitian women. Only one in three women had been screened for 
cervical cancer previously, one reason for high incidence and mortality from this disease in 
this setting. We also found large gaps in understanding of the causes and prevention of 
cervical cancer, even among the population most likely to have been screened. Given the 
almost universal interest in preventive methods, national screening programs linked to 
treatment would likely be well received.
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PRÉCIS
Among Haitian women, there are large gaps in understanding of cervical cancer causes 
and prevention strategies, highlighting the need for increased public health information.
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Table 1
Characteristics of the respondents (n= 410)1
Blanchard Léogâne Overall
n (%) n (%) n (%)
Demographic characteristics
 Age **
  18– 39 y 67 (41) 186 (74) 253 (62)
  ≥ 40 y 93 (59) 64 (26) 157 (38)
 Marital status
   Not married 59 (37) 111(44) 170 (41)
   Married or living together 101 (63) 139 (56) 240 (59)
 Education
   Primary education or less 66 (41) 82 (33) 148 (36)
   More than primary education 94 (59) 168 (67) 262 (64)
 Employment status**
   Unemployed or student 17 (11) 91 (36) 108 (26)
   Employed 143 (89) 159 (63) 302 (73)
 Religious background*
   Catholic 24 (15) 71 (28) 95(23)
   Other Christian/Protestant 128 (80) 159 (64) 287(70)
   Other/ No religion 8 (5) 20 (8) 28 (7)
 Have children **
  No 26 (16) 90 (36) 116 (28)
  Yes 134 (84) 160(64) 294 (72)
Personal health & disease awareness
 Had sexually transmitted infection**
   No 133 (83) 236 (94) 369 (90)
   Yes 27 (17) 14 (6) 41 (10)
 Contraceptive use**
   No 105 (66) 204 (82) 309 (75)
   Yes 55 (34) 46 (18) 101 (25)
 Heard of HPV**
  No 65 (41) 226 (90) 291 (71)
  Yes 95 (59) 24 (10) 119 (29)
 Heard of genital warts**
  No 90 (56) 217 (87) 307 (75)
  Yes 70 (44) 33 (13) 103 (25)
 Known someone with cervical cancer
  No 116 (73) 160 (64) 276 (67)
  Yes 44 (27) 90 (36) 134 (33)
1*P<.05,
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**P<.01
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Table 2
Beliefs about causes of cervical cancer (N=400)1
Responses %
Vaginal infection/ gynecological problems 51
Sexual behavior 41
Poor hygiene 21
Abortion 17
STI 12
Drinking unclean water 7
HPV 4
Birth control 3
Other 11
1Only women who were aware of cervical cancer answered this question.
Participants could list up to 3 answers. Responses in the “other” category included domestic violence, having many children, and inserting foreign 
matter into vagina.
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Table 3
Symptoms and outcomes of cervical cancer (N=400)1
Responses %
Vaginal issues 51
Frequent periods/bleeding 44
Death 36
General pain 17
Stomachache/abdominal pain 15
Treatment 12
Sickness/Illnesses 8
Infection 8
Sterile 6
STI 3
Weight loss 3
Other 7
1Only women who were aware of cervical cancer answered this question.
Participants could list up to 3 answers. Responses in the “other” category included stress/anxiety, inability to have sex, and miracles.
J Low Genit Tract Dis. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
McCarthy et al. Page 14
Table 4
Correlates of Pap smear receipt (N= 410)1
No. of women who have ever had a pap smear/total 
(%)
Bivariate OR
(95% CI)
Multivariable OR
(95% CI)
Overall 153/410 (37) N/A N/A
Demographic characteristics
 Age
  18–39 y 60/253 (24) Ref Ref
  ≥ 40 y 93/187 (50) 4.67 (3.04– 7.19)** 3.09 (1.77– 5.41)**
 Marital status
   Not married 103/240 (43) Ref –
   Married or living together 50/170 (29) 0.55 (0.37–0.84)** –
 Education
   Primary education or less 61/148 (41) Ref Ref
   More than primary education 92/262 (35) 0.77 (0.51– 1.17) 1.77(1.01–3.10)*
 Employment status
   Unemployed or student 16/108 (15) Ref Ref
   Employed 137/302 (45) 4.77 (2.68– 8.50)** 2.18 (1.09– 4.33)*
 Religious background
   Catholic 24/95 (25) Ref –
   Other Christian/Protestant 119/287 (41) 2.10 (1.25– 3.52)** –
   Other/ No religion 10/28 (36) 1.64 (0.67– 4.04) –
 Have children
  No 20/116 (17) Ref –
  Yes 133/294 (45) 3.97 (2.33– 6.76)** –
Personal health and health beliefs
 Had sexually transmitted infection
   No 124/369 (34) Ref Ref
   Yes 29/41 (71) 4.77 (2.36– 9.68)** 3.45 (1.57– 7.59)**
 Contraceptive use
   No 104/309 (34) Ref –
   Yes 49/101 (49) 1.86 (1.18– 2.93)** –
 Heard of HPV
  No 91/291 (31) Ref –
  Yes 62/119 (52) 2.39 (1.54–3.70)** –
 Heard of genital warts
  No 104/307 (34) Ref –
  Yes 49/103 (48) 1.77 (1.13– 2.79)* –
 Knew someone with cervical cancer
  No 101/276 (37) Ref –
  Yes 52/134 (38) 1.10 (0.72– 1.68) –
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1OR = Odds ratio; CI = confidence interval; Ref = Referent group; N/A = Not applicable. Dashes (−) indicate the variable was not included in the 
multivariable model because it was not statistically significant using a forward stepwise procedure. Multivariable model was also adjusted for clinic 
site.
*P<.05;
**P<.01
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Table 5
Reasons for desiring a Pap smear (N=399)1
Responses %
Prevention 89
Adherence to guidelines/ medical recommendation 14
Early treatment 9
Check for cancer 8
Symptoms 4
To know if I can have children 3
Other 11
1Only women who said they were willing to get a Pap smear answered this question.
Participants could list up to 3 answers. Responses in the “other” category included husband’s infidelity, a friend/sibling already got the test, and 
continued sexual activity.
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